Literature DB >> 23944930

Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis.

Tomo Osako1, Kengo Takeuchi, Rie Horii, Takuji Iwase, Futoshi Akiyama.   

Abstract

AIMS: Secretory carcinoma (SC) is a rare histological type of breast cancer, and ETV6-NTRK3 gene fusion is highly specific to it. The differential diagnoses of SC include acinic cell carcinoma (ACCA) and cystic hypersecretory carcinoma (CHC), as well as invasive ductal carcinoma (IDC). For patients with these rare but distinctive histological subtypes, SC and its histopathological mimics should be differentiated from each other. However, differential markers have not yet been assessed systematically, and we aimed to identify and evaluate novel and existing markers. METHODS AND
RESULTS: We reviewed 19 cases diagnosed initially as SC using integrated diagnostic techniques, including morphology, immunohistochemistry and molecular pathology, and validated promising markers in 445 breast cancers. We reclassified 19 formerly diagnosed 'SCs' into nine SCs, three ACCAs, three CHCs, three IDCs and one microglandular adenosis. We confirmed that ETV6-NTRK3 gene rearrangement and amylase positivity are good diagnostic markers for SC and ACCA, respectively. Vacuolar staining for adipophilin, positivity for α-lactalbumin and negativity for ETV6 rearrangement are diagnostic markers for CHC.
CONCLUSIONS: In this study, we propose a panel of four markers (ETV6 rearrangement, amylase, α-lactalbumin and adipophilin) for distinguishing SC, ACCA, CHC and IDC. This simple but robust panel will serve pathologists well as a practical guide for reaching an appropriate diagnosis.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  ETV6-NTRK3 gene rearrangement; acinic cell carcinoma; adipophilin; cystic hypersecretory carcinoma; secretory carcinoma

Mesh:

Substances:

Year:  2013        PMID: 23944930     DOI: 10.1111/his.12172

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Are acinic cell carcinomas of the breast and salivary glands distinct diseases?

Authors:  Salvatore Piscuoglio; Zsolt Hodi; Nora Katabi; Elena Guerini-Rocco; Gabriel S Macedo; Charlotte K Y Ng; Marcia Edelweiss; Leticia De Mattos-Arruda; Hannah Y Wen; Emad A Rakha; Ian O Ellis; Brian P Rubin; Britta Weigelt; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2015-03-23       Impact factor: 5.087

2.  Foamy cell (hibernoma-like) change is a rare histopathological feature in renal cell carcinoma.

Authors:  Fredrik Petersson; Maris Sperga; Stela Bulimbasic; Petr Martinek; Marian Svajdler; Naoto Kuroda; Milan Hora; Roderick Simpson; Tomáš Tichy; Kvetoslava Peckova; Jindrich Branzovsky; Kristyna Pivovarcikova; Pavla Rotterova; Bohuslava Kokoskova; Kevin Bauleth; Dusan Martincok; Vincent Nagy; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2014-06-06       Impact factor: 4.064

3.  Acinic cell carcinoma of breast: morphologic and immunohistochemical review of a rare breast cancer subtype.

Authors:  Niamh Conlon; Navid Sadri; Adriana D Corben; Lee K Tan
Journal:  Hum Pathol       Date:  2016-01-07       Impact factor: 3.466

4.  Morphologic and immunohistochemical features of carcinoma involving microglandular adenosis of the breast following neoadjuvant chemotherapy.

Authors:  Anne Grabenstetter; Timothy M D' Alfonso; Hannah Y Wen; Melissa Murray; Edi Brogi; Lee K Tan
Journal:  Mod Pathol       Date:  2021-03-01       Impact factor: 7.842

5.  Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.

Authors:  Felipe C Geyer; Samuel H Berman; Caterina Marchiò; Kathleen A Burke; Elena Guerini-Rocco; Salvatore Piscuoglio; Charlotte Ky Ng; Fresia Pareja; Hannah Y Wen; Zoltan Hodi; Stuart J Schnitt; Emad A Rakha; Ian O Ellis; Larry Norton; Britta Weigelt; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

6.  Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.

Authors:  Yuri Tolkach; Christine Lüders; Sebastian Meller; Klaus Jung; Carsten Stephan; Glen Kristiansen
Journal:  Oncotarget       Date:  2017-04-25

7.  Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma.

Authors:  Lijuan Li; Nan Wu; Fangxuan Li; Lingmei Li; Lijuan Wei; Juntian Liu
Journal:  Cancer Biol Med       Date:  2019-02       Impact factor: 4.248

8.  Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast.

Authors:  Piguo Gong; Chen Xia; Yifeng Yang; Wang Lei; Weiping Yang; Junhua Yu; Yishun Ji; Lijun Ren; Fugui Ye
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

Review 9.  Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review.

Authors:  Hongping Tang; Lihua Zhong; Hongbing Jiang; Yan Zhang; Guannan Liang; Guoyan Chen; Gui'e Xie
Journal:  Diagn Pathol       Date:  2021-06-24       Impact factor: 2.644

Review 10.  Pure acinic cell carcinoma of the breast: A case report and literature review.

Authors:  Hongmei Li; Fuzhi Wang; Pingrong Shen; Feng Zhou
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.